Centrally Acting Alpha2 Agonists

Centrally Acting Alpha2 Agonists

  • Category of drugs that treat hypertension, severe pain relief (via epidural injection), and management of ADHD.

Prototype and Other Medications

  • Prototype: Clonidine

Expected Pharmacologic Action

  • Exhibit antihypertensive effects by:

    • Selectively activating alpha2 receptors in the brainstem areas of the central nervous system (CNS).

    • This action results in:

      • Reduction of sympathetic stimulation of the heart and blood vessels.

      • Lowered blood pressure.

Adverse Drug Reactions

  • CNS effects including:

    • Drowsiness

    • Dizziness

  • Xerostomia (dry mouth)

  • Risk of rebound hypertensive crisis upon abrupt discontinuation of clonidine.

Interventions

  • Monitor for CNS effects such as drowsiness and dizziness.

  • Inform clients that:

    • Dry mouth will decrease over the first few weeks.

  • Follow tapering instructions for discontinuation over several days to avoid crisis.

Administration

  • Clonidine available in:

    • Oral form

    • Transdermal patch for hypertension treatment

  • Dosage guidelines:

    • Administer oral dose at bedtime to minimize daytime sedation; start low and increase gradually.

    • Apply the transdermal patch to a dry, relatively hairless area, such as the upper outer arm or anterior chest, every 7 days.

    • Rotate patch sites and monitor skin for irritation, ensuring the previous patch is removed before applying a new one.

Client Instructions

  • Take medications at bedtime to minimize CNS effects.

  • Avoid hazardous activities (e.g., driving) until effects are known.

  • For dry mouth, recommend:

    • Sucking on hard candy, chewing sugarless gum, or sipping water.

  • Assure clients that dry mouth diminishes over time.

  • Emphasize not stopping clonidine abruptly and follow tapering instructions upon discontinuation.

Safety Alert

  • Stimulation of CNS alpha2 receptors leads to decreased sympathetic outflow resulting in:

    • Passive dilation of blood vessels

    • Slowed heart rate

  • Stopping clonidine abruptly can lead to a hypertensive crisis due to rebound sympathetic nervous system outflow.

  • Monitor for potential abuse, particularly at high doses, revealing effects such as euphoria, sedation, and hallucinations.

Contraindications and Precautions

  • Avoid use in clients receiving anticoagulant therapy.

  • Use cautiously in clients with:

    • Severe cardiac disease

    • Cerebrovascular disease

    • Renal disorders.

Interactions

  • Clonidine increases sedation effects of:

    • CNS depressants (e.g., alcohol, antihistamines, opioid analgesics)

  • Antihypertensive effects may decline when used with:

    • MAO Inhibitors

    • Tricyclic antidepressants

    • Amphetamines.

robot